#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Epidermolysis bullosa Amyotrophic lateral sclerosis Systemic mastocytosis Renal transplant Frostbite Hodgkin's disease recurrent Toxic epidermal necrolysis Endometrial adenocarcinoma Measles Fibrosarcoma metastatic Thalassaemia beta ROHHAD syndrome Colon cancer Mucopolysaccharidosis II Paraganglion neoplasm More trials…

    Learn about Rare Diseases

    Mast cell activation syndrome – Diagnostics Urea cycle disorder – Basic Information Phenylketonuria Pituitary-dependent Cushing’s syndrome – Diagnostics Andersen-Tawil syndrome – Basic Information Richter’s syndrome – Diagnostics Glomerulonephritis rapidly progressive – Basic Information Haemophilia A with anti factor VIII – Trials in Disease Mitochondrial myopathy – Life with Disease Leukoencephalopathy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Omp10 Azilsartan Medoxomil Trametinib Dimethyl Sulfoxide Englumafusp Alfa Topotecan VISUGROMAB Timothy Grass Pollen Extract Raltegravir Cls12311 Ly3454738 Retinol Acetate Rbd4059 Fentanyl Citrate Bendamustine Hydrochloride Isis 678354 Sodium Salt Alizapride Midazolam Hydrochloride ULEFNERSEN Amg 193 Avalglucosidase Alfa More therapies…

    Learn about Your Condition

    Oesophageal achalasia Eczema Pouchitis Neurogenic bladder Lymphangiosarcoma Vulvovaginal pruritus Pyelonephritis acute Lyme disease Tendon injury Guttate psoriasis Cardiac failure acute Fatty acid oxidation disorder Angiopathy Glomerulonephritis chronic Chronic myeloid leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effects of Alglucosidase Alfa Enzyme Therapy in Children and Adults with Pompe Disease

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Glycogen storage disease type II
    Investigated Drugs:
    • Alglucosidase Alfa
    The Netherlands

  • Study on the Immune Response and Safety of a Second Dose of Investigational Varicella Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Varicella
    Investigated Drugs:
    • GSKVX000000025896
    • VARICELLA VIRUS OKA/MERCK STRAIN (LIVE, ATTENUATED)
    • VARICELLA VIRUS OKA/MERCK STRAIN, (LIVE, ATTENUATED) PRODUCED IN HUMAN DIPLOID (MRC-5) CELLS
    Denmark Norway

  • Study on the Effects of Apixaban Absorption in Patients Undergoing Roux-en-Y Gastric Bypass Surgery

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Charcoal, Activated
    • Human Coagulation Factor Ii
    • Human Coagulation Factor Ix
    The Netherlands

  • Study on the Spread of LetibotulinumtoxinA Compared to OnabotulinumtoxinA and AbobotulinumtoxinA in Patients with Moderate to Severe Forehead Wrinkles

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    • Botulinum Toxin Type A
    Germany

  • Study Comparing the Effectiveness and Safety of Botulinum Toxin Type A Products for Treating Frown Lines in Adults

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Skin wrinkling
    Investigated Drugs:
    • Botulinum Toxin Type A – Haemagglutinin Complex
    • Botulinum Toxin Type A
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    The Netherlands

  • Study on Improving Social Interaction in Children with Autism Using Oxytocin Nasal Spray and Therapy

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Autism spectrum disorder
    Investigated Drugs:
    • Oxytocin
    Belgium
Previous Page
1 … 804 805 806 807 808 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!